All In MedTech

Device Trial Radar · NCT02255851

Sentinel(TM) Post-Market Registry

Histopathology of Embolic Debris Captured During Transcatheter Aortic Valve Replacement

Last checked: Nov 20, 2026Latest source record: May 23, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

300

Actual

Start

Mar 2014

Primary completion

May 2016

Study completion May 2016

Sponsor

Lead sponsor
Claret MedicalNot on our public-company list
Sponsor type
Industry
First posted
Oct 3, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The SENTINEL Post-Market Registry is a prospective, multi-center, registry using the CE-Marked Sentinel System in subjects with severe symptomatic calcified native aortic valve stenosis indicated for TAVR. Subjects enrolled in the registry will undergo TAVR + Sentinel. Basic demographic information and detailed procedural data will be captured and documented in a registry case report form. All Sentinel filters will be sent for histopathology at an independent core-lab.

Conditions

  • Transcatheter Aortic Valve Replacement
  • Severe Symptomatic Calcified Native Aortic Valve Stenosis

Interventions

  • SENTINEL (Cerebral Protection System)Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Observational EndpointTime frame: Post-Procedure (day 1)

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.